Quattrone, Diego
 Distribuzione geografica
Continente #
NA - Nord America 4.809
EU - Europa 3.451
AS - Asia 2.784
SA - Sud America 481
AF - Africa 97
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.640
Nazione #
US - Stati Uniti d'America 4.689
IT - Italia 1.037
SG - Singapore 1.036
RU - Federazione Russa 881
CN - Cina 608
DE - Germania 543
BR - Brasile 375
HK - Hong Kong 311
PL - Polonia 225
VN - Vietnam 218
BD - Bangladesh 192
FR - Francia 177
GB - Regno Unito 160
JP - Giappone 95
FI - Finlandia 92
NL - Olanda 59
CA - Canada 57
IN - India 56
IE - Irlanda 52
KR - Corea 42
AT - Austria 38
TR - Turchia 38
ES - Italia 36
SE - Svezia 33
IQ - Iraq 32
AR - Argentina 31
RO - Romania 31
MX - Messico 30
CI - Costa d'Avorio 21
ZA - Sudafrica 21
UA - Ucraina 17
ID - Indonesia 16
EC - Ecuador 15
VE - Venezuela 15
AU - Australia 14
BE - Belgio 14
MY - Malesia 14
SA - Arabia Saudita 14
CL - Cile 13
PK - Pakistan 13
KE - Kenya 12
UZ - Uzbekistan 12
GR - Grecia 11
JO - Giordania 11
TW - Taiwan 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
CO - Colombia 10
EG - Egitto 10
MA - Marocco 10
IR - Iran 9
PH - Filippine 9
PY - Paraguay 9
CR - Costa Rica 6
JM - Giamaica 6
KZ - Kazakistan 6
LT - Lituania 6
TN - Tunisia 6
AL - Albania 5
UY - Uruguay 5
BG - Bulgaria 4
BO - Bolivia 4
PE - Perù 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BB - Barbados 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
NE - Niger 2
PA - Panama 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 11.621
Città #
Singapore 689
Ashburn 667
Fairfield 460
San Jose 432
Hong Kong 290
Palermo 235
Chandler 225
Zgierz 206
Woodbridge 196
Houston 191
Seattle 159
Wilmington 159
Dallas 141
Ann Arbor 126
Cambridge 126
Moscow 122
Los Angeles 119
Hefei 110
Beijing 103
Council Bluffs 98
Lauterbourg 91
Tokyo 84
Ho Chi Minh City 83
Medford 78
Boardman 74
Rome 73
New York 71
Lappeenranta 66
Buffalo 54
Santa Clara 51
Chicago 50
Dublin 49
Hanoi 49
Milan 49
Des Moines 48
The Dalles 47
Altamura 45
Princeton 44
Lawrence 41
London 38
San Diego 36
Nuremberg 35
São Paulo 31
Frankfurt am Main 30
Seoul 29
Ludwigshafen am Rhein 27
Helsinki 24
Orem 23
Abidjan 21
Amsterdam 19
Naples 19
Atlanta 16
Brooklyn 16
Columbus 16
Florence 16
Johannesburg 16
Redwood City 15
Rio de Janeiro 15
Alimena 14
Paris 14
Vienna 14
Dearborn 13
Falls Church 13
Montreal 13
Nanjing 13
Salt Lake City 13
San Paolo di Civitate 13
Warsaw 13
Washington 13
Istanbul 11
Messina 11
Phoenix 11
Toronto 11
Tower Hamlets 11
Bologna 10
Brussels 10
Central 10
Denver 10
Erbil 10
Melbourne 10
Redondo Beach 10
San Francisco 10
Tashkent 10
Amman 9
Baghdad 9
Bari 9
Boston 9
Da Nang 9
Elk Grove Village 9
Manchester 9
Mexico City 9
Munich 9
Nairobi 9
Shanghai 9
Turin 9
Chennai 8
Haiphong 8
Kumar 8
Noblesville 8
Poplar 8
Totale 6.882
Nome #
Interplay Between Childhood Maltreatment, Subclinical Post-Traumatic Stress Symptoms, and IQ: Findings From the EU-GEI Multicentre Case–Control Study 427
Treated incidence of psychotic disorders in the multinational EU-GEI study 271
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU GEI study 264
Prevalence and Risk Factors for Internet Gaming Disorder (IGD) in a sample of 5,979 Italian Online Gamers 241
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study 239
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study 233
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use 230
Differences between female and male gamers and gender-specific risk-factors for internet gaming disorder (IGD) 226
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls 222
Risk factors for internet gaming disorder in a sample of 5,979 italian online gamers. 220
DOES POLYGENIC RISK SCORE FOR SCHIZOPHRENIA IMPACT ON JUMPING TO CONCLUSIONS? PRELIMINARY FINDINGS FROM THE EU-GEI CASE-CONTROL STUDY 219
BIOLOGICAL AND EPIDEMIOLOGICAL EXAMINATION OF TRANSDIAGNOSTIC AND SPECIFIC SYMPTOM DIMENSIONS AT PSYCHOSIS ONSET: FINDINGS FROM THE EUGEI STUDY 216
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study 212
Psychological distress and suicidal ideation in Sicilian Medical Students: The SMS-ME project 208
Are Polygenic Risk Scores for Major Mental Disorders Associated with General or Specific Psychosis Symptom dimensions? 205
F115POLYGENIC RISK SCORES FOR SCHIZOPHRENIA, BIPOLAR, AND MAJOR DEPRESSIVE DISORDERS PREDICT TRANSDIAGNOSTIC SYMPTOM DIMENSIONS AT FIRST EPISODE PSYCHOSIS 199
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 199
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 196
IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use. 189
What does augment the risk to use cannabis on an everyday-basis in psychotic patients? 185
O4.8. CAN YOU SPOT EMOTIONS? FACIAL EMOTION RECOGNITION AND GENETIC RISK FOR PSYCHOSIS 182
The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia 179
FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS 178
Beyond the Gender Binarism: Neural Correlates of Trans Men in a Functional Connectivity–Resting-State fMRI Pilot Study 177
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings 172
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme 168
DOES CANNABIS USE WORSEN PSYCHOTIC SYMPTOM PRESENTATION? 157
FIRST EPISODE PSYCHOSIS PATIENTS WHO USED CANNABIS DEVELOP THEIR ILLNESS AT A SIGNIFICANTLY YOUNGER AGE THAN THOSE WHO NEVER USED CONSISTENTLY ACROSS EUROPE AND BRAZIL 150
COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY 143
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: Results from the EU-GEI case-control study 141
O3.1. ASSOCIATION OF EXTENT OF CANNABIS USE AND ACUTE INTOXICATION EXPERIENCES IN A MULTI-NATIONAL SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS AND CONTROLS 140
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study 134
Neurobiological and Anti-Inflammatory Effects of a Deep Diaphragmatic Breathing Technique Based on Neofunctional Psychotherapy: A Pilot RCT 130
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IMPAIRMENT IN FIRST EPISODE PSYCHOSIS ACROSS EUROPE 130
IS THE ERA OF CANDIDATE GENES X CANNABIS USE REALLY DEAD? 129
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study 127
BEHAVIOURAL PREDICTORS OF WEIGHT LOSS MAINTENANCE AFTER BARIATRIC SURGERY: A SCOPING REVIEW 126
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI) 126
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors 124
T42. JUMPING TO CONCLUSIONS IS ASSOCIATED WITH THE POLYGENIC RISK SCORE FOR INTELLIGENCE BUT NOT FOR SCHIZOPHRENIA. PRELIMINARY FINDINGS FROM THE EU-GEI STUDY 124
SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE 121
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study 118
The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: Findings from the multinational EU-GEI study 117
FIRST EPISODE PSYCHOSIS PATIENTS ACROSS EUROPE DIFFER IN INTELLECTUAL QUOTIENT (IQ) AND EXPOSURE TO ENVIRONMENTAL HAZARDS 113
35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS 109
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IN FIRST-EPISODE PSYCHOSIS: LONGITUDINAL INSIGHTS FROM THE GAP FOLLOW-UP STUDY 109
Tobacco use in first-episode psychosis, a multinational EU-GEI study 107
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data 102
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings 101
A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders 99
Migration history and risk of psychosis: Results from the multinational EU-GEI study 97
Genetics for mental health clinicians: a call for a globally accessible and equitable psychiatric genetics education 96
EXPLORING SPECIFIC EFFECTS OF TYPE AND TIMING OF EXPOSURE TO CHILDHOOD ADVERSITY AND SYMPTOM DOMAINS IN FIRST EPISODE OF PSYCHOSIS: PRELIMINARY RESULTS FROM THE EUGEI PROJECT 93
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia 92
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study 92
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study 92
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project 91
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 90
P.0170 Distinct polygenic risk scores in clusters of psychotic subjects with different premorbid trajectories and current IQ 89
58.1 Cannabis use Across Europe: A Ticket to Psychosis? 89
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 88
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 87
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 86
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study 86
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study 86
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study 85
Antipsychotic dose mediates the association between polypharmacy and corrected QT interval 83
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study 82
Early parental death and risk of psychosis in offspring: A six-country case-control study 78
ENVIRONMENTAL RISK FACTORS DIFFERENCES AMONG DIAGNOSTIC CATEGORIES IN EU-GEI STUDY 77
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study 74
P.0171 The independent and joint effect of the endocannabinoid system and daily cannabis use on the risk of psychosis 73
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis 70
Methylomic signature of current cannabis use in two first-episode psychosis cohorts 70
Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study 69
Duration of Untreated Psychosis in First-Episode Psychosis is not Associated with Common Genetic Variants for Major Psychiatric Conditions: Results from the Multi-Center EU-GEI Study 69
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study 68
The Kraepelian concept of schizophrenia: Dying but not yet dead 68
Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis 67
SA11DO PRS FOR SQUIZOPHRENIA, BIPOLAR DISORDER AND MAJOR DEPRESSION DISTINGUISH BETWEEN AFFECTIVE-PSYCHOSIS DIAGNOSTIC CATEGORIES? THE EUGEI STUDY 67
Unraveling Exercise Addiction: The Role of Narcissism and Self-Esteem 67
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings from the Multinational EU-GEI Study 67
SU132CANNABIS USE AND SCHIZOPHRENIA: CAN GENETICS TELL IF IS IT "THE CHICKEN OR THE EGG"? 66
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis 64
Differential gene expression analysis in blood of first episode psychosis patients 64
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study 63
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 61
Novel psychoactive substances and induced phenomena in psychopathology: The lysergic psychoma 58
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies 57
The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use 56
W73. GENETIC AND SOCIOENVIROMENTAL CORRELATES OF SYMPTOM DIMENSIONS ACROSS THE PSYCHOSIS SPECTRUM AT BASELINE AND 10-YEAR FOLLOW-UP 55
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 54
Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study 54
Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis? 52
Novel psychoactive substances in young adults with and without psychiatric comorbidities 52
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe 51
Do Idiopathic Parkinson's Disease and Schizophrenia Lie on the Same Genetic Spectrum? 50
Does personality matter? Temperament and character dimensions in panic subtypes 48
First-generation antipsychotics and QTc: any role for mediating variables? 48
The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder 47
Totale 12.222
Categoria #
all - tutte 45.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 0 76
2021/2022729 46 93 30 34 34 67 28 110 58 62 61 106
2022/2023852 82 151 32 58 82 149 60 52 92 16 61 17
2023/2024773 14 50 17 79 46 58 89 33 1 54 38 294
2024/20251.944 167 80 82 157 81 76 158 147 172 220 213 391
2025/20266.152 367 194 486 840 556 690 850 650 501 394 429 195
Totale 12.478